From: Comprehensive analysis of peroxiredoxins expression profiles and prognostic values in breast cancer
PRDXs | Deep deletion | Shallow deletion | Dipliod | Gain | Amplification |
---|---|---|---|---|---|
PRDX1 | 0 (0.00%) | 297 (27.60%) | 623 (57.90%) | 143 (13.29%) | 13 (1.21%) |
PRDX2 | 1 (0.09%) | 226 (21.00%) | 646 (60.04%) | 186 (17.29%) | 17 (1.58%) |
PRDX3 | 1 (0.09%) | 321 (29.83%) | 651 (60.50%) | 98 (9.11%) | 5 (0.46%) |
PRDX4 | 3 (0.28%) | 184 (17.10%) | 706 (65.61%) | 168 (15.61%) | 15 (1.39%) |
PRDX5 | 1 (0.09%) | 242 (22.49) | 657 (61.06%) | 167 (15.52%) | 9 (0.84%) |
PRDX6 | 0 (0.00%) | 24 (2.23%) | 262 (24.35%) | 689 (64.03%) | 101 (9.39%) |